Naiba Nabieva

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2025
ChatGPT's Agreement with the Recommendations from the 18th St. Gallen International Consensus Conference on the Treatment of Early Breast Cancer.

Naiba Nabieva, Sara Y Brucker, Benjamin Gmeiner

|Sep 28, 2023
Editorial for the Special Issue "Breast Cancer-Therapeutic Challenges, Research Strategies and Novel Diagnostics".

Naiba Nabieva

|Mar 29, 2023
CDK4/6 Inhibitors-Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer.

Naiba Nabieva, Peter A Fasching

|Apr 12, 2022
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.

Hanna Huebner, Lothar Häberle, Volkmar Müller

|Mar 23, 2019
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.

Naiba Nabieva, Lothar Häberle, Sara Y Brucker

Pageof 1

Frequent Collaborators

3 joint publications

Peter A Fasching

1 joint publications

Lothar Häberle

1 joint publications

Paul Gass

1 joint publications

Hanna Huebner